Neurogen Biomarking is expanding its home-based Alzheimer’s testing model through a partnership with Tasso, which will supply its needle-free blood collection devices for use across Neurogen’s ...

Given the opportunity, 90% of Americans say they would take a blood biomarker test for Alzheimer’s disease (AD) — even in the absence of symptoms. Notably, 80% say they wouldn’t wait for a physician ...